Pharmaceutical Content Synthesis via User-Specific Templates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Generating different media content items regarding a pharmaceutical article for various user types is resource-intensive due to the need for tailored information and presentation styles suited to each user's level of engagement and understanding.

Innovation Solution

A device and method that synthesize pharmaceutical content items by populating content templates specific to each user type, based on expected engagement values, to provide relevant information in appropriate formats, reducing unnecessary resource usage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If pharmaceutical content items are generated for multiple user types with tailored information and presentation styles, then the relevance and engagement of content is improved, but the resource consumption and power usage increase

Engineering Contradiction:
Improvecontent relevance to user typeVSAvoidpower consumption
Core Design Contradiction:
Adaptability or versatilityVSUse of energy by moving object

Solution Approach 1:

The patent segments content generation by creating separate content templates for different user types (e.g., patients, healthcare providers, payers). Each template is tailored to specific user needs and engagement levels, allowing the system to generate only the relevant content subset for each user type rather than generating all possible content variations, thus reducing overall resource consumption while maintaining high relevance.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by customizing content characteristics (information depth, presentation style, engagement level) specifically for each user type. The system determines expected engagement values for different user types and adjusts content properties locally according to these values, ensuring optimal relevance for each segment while avoiding the energy cost of generating fully customized content for every possible user scenario.

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If content templates are customized for each user type based on expected engagement values, then the engagement quality is improved, but the device complexity increases

Engineering Contradiction:
Improvecontent customization for user typesVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements preliminary action by pre-defining content templates for different user types based on expected engagement values. These templates are prepared in advance with appropriate information depth, presentation styles, and engagement characteristics. When generating content, the system simply selects and populates the appropriate pre-defined template rather than creating customized content from scratch, significantly reducing computational complexity while maintaining high adaptability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses parameter changes by adjusting content properties (information depth, engagement level, presentation format) based on user type and expected engagement values. The system modifies template parameters dynamically to match the target user type without requiring complete template redesign, balancing customization needs with system simplicity.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250125026A1Pharmaceutical content generation based on user type
Publication Date: 2025.04.17 ACTO TECH INC
  • US20250125026A1 patent drawing
  • US20250125026A1 patent drawing
  • US20250125026A1 patent drawing

AI summary

Various implementations disclosed herein include devices, systems, and methods for tailoring information regarding a pharmaceutical article to user types. In various implementations, a device includes a non-transitory memory and a processor coupled with the non-transitory memory. In some implementations, a method includes obtaining a request to synthesize a plurality of pharmaceutical content items for respective user types. In some implementations, the plurality of pharmaceutical content items provides information regarding a pharmaceutical article. In some implementations, the method includes determining, for the respective user types, corresponding expected engagement values indicative of expected engagement with the subject. In some implementations, the method includes determining, based on the corresponding expected engagement values, respective content templates for the plurality of pharmaceutical content items. In some implementations, the method incudes synthesizing the plurality of pharmaceutical content items by populating the respective content templates with information regarding the pharmaceutical article.